Wake up Symptomatic Stroke in Acute Brain Ischemia (WASSABI) Trial

Trial Profile

Wake up Symptomatic Stroke in Acute Brain Ischemia (WASSABI) Trial

Phase of Trial: Phase II

Latest Information Update: 27 Feb 2017

At a glance

  • Drugs Alteplase (Primary) ; Aspirin/dipyridamole (Primary) ; Atorvastatin (Primary) ; Clopidogrel (Primary) ; Rosuvastatin (Primary) ; Antiplatelets; Aspirin
  • Indications Embolism and thrombosis; Stroke
  • Focus Therapeutic Use
  • Acronyms WASSABI
  • Most Recent Events

    • 29 Mar 2012 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
    • 26 Oct 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top